Drug Agency Retains Approval of Hanmi’s Controversial Lung Cancer Drug

SEOUL, Oct. 4 (Korea Bizwire) – South Korea’s health authorities said Tuesday that they have decided to “conditionally” maintain sales approval for a controversial lung cancer treatment developed by the country’s leading drugmaker Hanmi Pharmaceutical Co. amid side effect concerns.  The Ministry of Food and Drug Safety (MFDS) said it will maintain an earlier decision [...]